These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15878996)

  • 1. Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma.
    Belvisi MG; Bundschuh DS; Stoeck M; Wicks S; Underwood S; Battram CH; Haddad el-B; Webber SE; Foster ML
    J Pharmacol Exp Ther; 2005 Aug; 314(2):568-74. PubMed ID: 15878996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide.
    Stoeck M; Riedel R; Hochhaus G; Häfner D; Masso JM; Schmidt B; Hatzelmann A; Marx D; Bundschuh DS
    J Pharmacol Exp Ther; 2004 Apr; 309(1):249-58. PubMed ID: 14718604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: A comparison of ciclesonide and fluticasone propionate.
    Kaliner MA
    Clin Ther; 2006 Mar; 28(3):319-31. PubMed ID: 16750447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciclesonide--a novel corticosteroid for the management of asthma.
    Chopra D; Bhandari B; Wardhan N
    Curr Clin Pharmacol; 2012 May; 7(2):73-7. PubMed ID: 22283615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide.
    Rohatagi S; Luo Y; Shen L; Guo Z; Schemm C; Huang Y; Chen K; David M; Nave R; King SP
    Am J Ther; 2005; 12(3):201-9. PubMed ID: 15891262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ciclesonide and fluticasone propionate on allergen-induced airway inflammation and remodeling features.
    Leung SY; Eynott P; Nath P; Chung KF
    J Allergy Clin Immunol; 2005 May; 115(5):989-96. PubMed ID: 15867856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma.
    Richter K; Kanniess F; Biberger C; Nave R; Magnussen H
    J Clin Pharmacol; 2005 Feb; 45(2):146-52. PubMed ID: 15647406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalent pharmacokinetics of the active metabolite of ciclesonide with and without use of the AeroChamber Plus spacer for inhalation.
    Drollmann A; Nave R; Steinijans VW; Baumgärtner E; Bethke TD
    Clin Pharmacokinet; 2006; 45(7):729-36. PubMed ID: 16802853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic disposition of inhaled ciclesonide and its metabolite desisobutyryl-ciclesonide in healthy subjects and patients with asthma are similar.
    Nave R; Gunawardena KA; Zech K; Bethke TD
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):1-7. PubMed ID: 16425964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciclesonide: a novel inhaled corticosteroid.
    Humbert M
    Expert Opin Investig Drugs; 2004 Oct; 13(10):1349-60. PubMed ID: 15461563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciclesonide: a novel inhaled corticosteroid for asthma.
    Christie P
    Drugs Today (Barc); 2004 Jul; 40(7):569-76. PubMed ID: 15510231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of human lung fibroblast functions by ciclesonide: evidence for its conversion into the active metabolite desisobutyryl-ciclesonide.
    Boero S; Sabatini F; Silvestri M; Petecchia L; Nachira A; Pezzolo A; Scarso L; Rossi GA
    Immunol Lett; 2007 Sep; 112(1):39-46. PubMed ID: 17707916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciclesonide: A Pro-Soft Drug Approach for Mitigation of Side Effects of Inhaled Corticosteroids.
    Mukker JK; Singh RSP; Derendorf H
    J Pharm Sci; 2016 Sep; 105(9):2509-2514. PubMed ID: 27339407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of effectiveness in ciclesonide and fluticasone propionate on small airway function in mild asthma.
    Hoshino M
    Allergol Int; 2010 Mar; 59(1):59-66. PubMed ID: 20035146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ciclesonide -- a new inhaled corticosteroid].
    Ukena D
    Pneumologie; 2005 Oct; 59(10):689-95. PubMed ID: 16222581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference between patient-reported side effects of ciclesonide versus fluticasone propionate.
    van der Molen T; Foster JM; Caeser M; Müller T; Postma DS
    Respir Med; 2010 Dec; 104(12):1825-33. PubMed ID: 20584595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonide.
    Nave R; Meyer W; Fuhst R; Zech K
    Pulm Pharmacol Ther; 2005; 18(6):390-6. PubMed ID: 16179214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma.
    Buhl R; Vinkler I; Magyar P; Györi Z; Rybacki C; Middle MV; Escher A; Engelstätter R
    Pulm Pharmacol Ther; 2006; 19(6):404-12. PubMed ID: 16310388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
    Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J
    Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated-dose pharmacokinetics of inhaled ciclesonide (CIC-HFA) in Japanese children with bronchial asthma: a phase I study.
    Teramoto T; Matsui E; Fukao T; Sakai K; Yonezawa H; Kato Z; Ohnishi H; Kaneko H; Kondo N; Azuma J; Nishima S
    Allergol Int; 2012 Dec; 61(4):619-24. PubMed ID: 23000724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.